The Expression of MTs in Hepatocellular Carcinoma and Its Clinical Significance

YI Shi-jian,ZHONG De-wu,YANG Zhu-lin

DOI: https://doi.org/10.3969/j.issn.2095-1116.2006.04.016

2006-01-01

Abstract:Objective To study the expression of MTs in HCC and the relationship between the expression and clinical pathological characterization.Methods 48 fresh resected specimens from the patients with HCC and 10 normal liver tissue were selected,fixed with 10% formalin,paraffin embed in routine,each sample were proceed serial section,about 4 μm thick,tissue section of HCC were stained by SABC immunohistochemistry,with MTs in HCC and the relationship between the expression and clinical pathological characterization were studied with X2 check,t check and Fisher precise probability.Results Positive rates of MTs in the tissue ofHCC were 60.42%,it was obviously lower than paracarcinoma tissue and normal liver tissue(P<(0.05));The scores of MTs in well ﹑middle and poorly differentiated HCC were 3.00±1.17﹑2.36±1.65 and 1.85±1.76,respectively.The scores of MTs in well-differentiated HCC were significantly higher than those in poorly-differentiated cancer(P<0.05);The expression of MTS was not associated with other pathological characterization.Conclusion The expression of MTs in the tissue of HCC was obviously lower than paracarcinoma tissue and normal liver tissue,and it was associated with differentiation degree of HCC.It showed that MTS restrained possibly the occurrence and development of HCC.